Genistein directly inhibits native and recombinant NMDA receptors

Renqi Huang, Meharvan Singh, Glenn H. Dillon

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The protein tyrosine kinase (PTK) inhibitor genistein has been widely used to examine potential effects of tyrosine phosphorylation on neurotransmitter function. We report here that genistein inhibits N-methyl-d-aspartate (NMDA) receptors through a direct effect. Whole-cell NMDA-activated current was recorded in native receptors from mouse hippocampal slice culture and rat recombinant NR1aNR2A and NR1aNR2B receptors transiently expressed in HEK293 cells. Extracellular application of genistein and NMDA reversibly inhibited NMDA-activated current. The inhibition of NMDA-activated current by genistein applied externally was not affected when genistein was also pre-equilibrated in the intracellular solution. Daidzein, an analog of genistein that does not block PTK, also inhibited NMDA-activated current. Coapplication of lavendustin A, a specific inhibitor of PTK, had no effect on the NMDA response. Moreover, genistein-induced inhibition of NMDA-activated current displayed concentration- and voltage-dependence. Our results demonstrate that genistein has a direct inhibitory effect on NMDA receptors that is not mediated via inhibition of tyrosine kinase. Thus, other PTK inhibitors may be more suitable for studying involvement of PTKs in NMDA receptor-mediated events.

Original languageEnglish
Pages (from-to)1246-1251
Number of pages6
JournalNeuropharmacology
Volume58
Issue number8
DOIs
StatePublished - 1 Jun 2010

Fingerprint

Genistein
Aspartic Acid
Protein-Tyrosine Kinases
Protein Kinase Inhibitors
aspartic acid receptor
HEK293 Cells
Neurotransmitter Agents
Tyrosine
Phosphorylation

Cite this

Huang, Renqi ; Singh, Meharvan ; Dillon, Glenn H. / Genistein directly inhibits native and recombinant NMDA receptors. In: Neuropharmacology. 2010 ; Vol. 58, No. 8. pp. 1246-1251.
@article{3484f01bcf8341898b4fe620d6a4a6f6,
title = "Genistein directly inhibits native and recombinant NMDA receptors",
abstract = "The protein tyrosine kinase (PTK) inhibitor genistein has been widely used to examine potential effects of tyrosine phosphorylation on neurotransmitter function. We report here that genistein inhibits N-methyl-d-aspartate (NMDA) receptors through a direct effect. Whole-cell NMDA-activated current was recorded in native receptors from mouse hippocampal slice culture and rat recombinant NR1aNR2A and NR1aNR2B receptors transiently expressed in HEK293 cells. Extracellular application of genistein and NMDA reversibly inhibited NMDA-activated current. The inhibition of NMDA-activated current by genistein applied externally was not affected when genistein was also pre-equilibrated in the intracellular solution. Daidzein, an analog of genistein that does not block PTK, also inhibited NMDA-activated current. Coapplication of lavendustin A, a specific inhibitor of PTK, had no effect on the NMDA response. Moreover, genistein-induced inhibition of NMDA-activated current displayed concentration- and voltage-dependence. Our results demonstrate that genistein has a direct inhibitory effect on NMDA receptors that is not mediated via inhibition of tyrosine kinase. Thus, other PTK inhibitors may be more suitable for studying involvement of PTKs in NMDA receptor-mediated events.",
author = "Renqi Huang and Meharvan Singh and Dillon, {Glenn H.}",
year = "2010",
month = "6",
day = "1",
doi = "10.1016/j.neuropharm.2010.03.006",
language = "English",
volume = "58",
pages = "1246--1251",
journal = "Neuropharmacology",
issn = "0028-3908",
publisher = "Elsevier Ltd",
number = "8",

}

Genistein directly inhibits native and recombinant NMDA receptors. / Huang, Renqi; Singh, Meharvan; Dillon, Glenn H.

In: Neuropharmacology, Vol. 58, No. 8, 01.06.2010, p. 1246-1251.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Genistein directly inhibits native and recombinant NMDA receptors

AU - Huang, Renqi

AU - Singh, Meharvan

AU - Dillon, Glenn H.

PY - 2010/6/1

Y1 - 2010/6/1

N2 - The protein tyrosine kinase (PTK) inhibitor genistein has been widely used to examine potential effects of tyrosine phosphorylation on neurotransmitter function. We report here that genistein inhibits N-methyl-d-aspartate (NMDA) receptors through a direct effect. Whole-cell NMDA-activated current was recorded in native receptors from mouse hippocampal slice culture and rat recombinant NR1aNR2A and NR1aNR2B receptors transiently expressed in HEK293 cells. Extracellular application of genistein and NMDA reversibly inhibited NMDA-activated current. The inhibition of NMDA-activated current by genistein applied externally was not affected when genistein was also pre-equilibrated in the intracellular solution. Daidzein, an analog of genistein that does not block PTK, also inhibited NMDA-activated current. Coapplication of lavendustin A, a specific inhibitor of PTK, had no effect on the NMDA response. Moreover, genistein-induced inhibition of NMDA-activated current displayed concentration- and voltage-dependence. Our results demonstrate that genistein has a direct inhibitory effect on NMDA receptors that is not mediated via inhibition of tyrosine kinase. Thus, other PTK inhibitors may be more suitable for studying involvement of PTKs in NMDA receptor-mediated events.

AB - The protein tyrosine kinase (PTK) inhibitor genistein has been widely used to examine potential effects of tyrosine phosphorylation on neurotransmitter function. We report here that genistein inhibits N-methyl-d-aspartate (NMDA) receptors through a direct effect. Whole-cell NMDA-activated current was recorded in native receptors from mouse hippocampal slice culture and rat recombinant NR1aNR2A and NR1aNR2B receptors transiently expressed in HEK293 cells. Extracellular application of genistein and NMDA reversibly inhibited NMDA-activated current. The inhibition of NMDA-activated current by genistein applied externally was not affected when genistein was also pre-equilibrated in the intracellular solution. Daidzein, an analog of genistein that does not block PTK, also inhibited NMDA-activated current. Coapplication of lavendustin A, a specific inhibitor of PTK, had no effect on the NMDA response. Moreover, genistein-induced inhibition of NMDA-activated current displayed concentration- and voltage-dependence. Our results demonstrate that genistein has a direct inhibitory effect on NMDA receptors that is not mediated via inhibition of tyrosine kinase. Thus, other PTK inhibitors may be more suitable for studying involvement of PTKs in NMDA receptor-mediated events.

UR - http://www.scopus.com/inward/record.url?scp=77952872947&partnerID=8YFLogxK

U2 - 10.1016/j.neuropharm.2010.03.006

DO - 10.1016/j.neuropharm.2010.03.006

M3 - Article

C2 - 20303997

AN - SCOPUS:77952872947

VL - 58

SP - 1246

EP - 1251

JO - Neuropharmacology

JF - Neuropharmacology

SN - 0028-3908

IS - 8

ER -